SAN DIEGO, October 25 — Aclara BioSciences and Third Wave Technologies on Thursday announced a collaboration to develop and commercialize multiplexed gene expression research products that couple Aclara’s eTag sequence-labeling technology with Third Wave's Invader platform. 

The companies said that their combined technologies would enable customers to profile many genes simultaneously in a single reaction directly from crude cell lysates, without the need for sample prep or PCR. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.